In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
- PMID: 32627074
- DOI: 10.1007/s00204-020-02836-w
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor
Erratum in
-
Correction to: In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.Arch Toxicol. 2020 Oct;94(10):3461. doi: 10.1007/s00204-020-02863-7. Arch Toxicol. 2020. PMID: 32789674
Abstract
Serotonergic psychedelics, substances exerting their effects primarily through the serotonin 2A receptor (5-HT2AR), continue to comprise a substantial portion of reported new psychoactive substances (NPS). The exact mechanisms of action of psychedelics still remain to be elucidated further, and certain pathways remain largely unexplored on a molecular level for this group of compounds. A systematic comparison of substances belonging to different subclasses, monitoring the receptor-proximal β-arrestin 2 recruitment, is lacking. Based on a previously reported in vitro bioassay employing functional complementation of a split nanoluciferase to monitor β-arrestin 2 recruitment to the 5-HT2AR, we here report on the setup of a stable HEK 293 T cell-based bioassay. Following verification of the performance of this new stable cell system as compared to a system based on transient transfection, the stable expression system was deemed suitable for the pharmacological characterization of psychedelic NPS. Subsequently, it was applied for the in vitro assessment of the structure-activity relationship of a set of 30 substances, representing different subclasses of phenylalkylamine psychedelics, among which 12 phenethylamine derivatives (2C-X), 7 phenylisopropylamines (DOx) and 11 N-benzylderivatives (25X-NB). The resulting potency and efficacy values provide insights into the structure-activity relationship of the tested compounds, overall confirm findings observed with other reported in vitro assays, and even show a significant correlation with estimated common doses. This approach, in which a large series of psychedelic NPS belonging to different subclasses is comparatively tested, using a same assay setup, monitoring a receptor-proximal event, not only gives pharmacological insights, but may also allow prioritization of legal actions related to the most potent -and potentially dangerous- compounds.
Keywords: Bioassay; Hallucinogen; New psychoactive substances; Psychedelic; Serotonin receptor; Structure–activity relationship.
Similar articles
-
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays.Biochem Pharmacol. 2020 Dec;182:114251. doi: 10.1016/j.bcp.2020.114251. Epub 2020 Sep 28. Biochem Pharmacol. 2020. PMID: 32998000
-
Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances.Anal Chem. 2019 Dec 17;91(24):15444-15452. doi: 10.1021/acs.analchem.9b03104. Epub 2019 Nov 27. Anal Chem. 2019. PMID: 31725281
-
Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine (25H-NBF) Positional Isomers.ACS Chem Neurosci. 2021 May 5;12(9):1667-1673. doi: 10.1021/acschemneuro.1c00124. Epub 2021 Apr 28. ACS Chem Neurosci. 2021. PMID: 33906351
-
In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT2A R.J Neurochem. 2022 Jul;162(1):39-59. doi: 10.1111/jnc.15570. Epub 2022 Jan 17. J Neurochem. 2022. PMID: 34978711 Review.
-
Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics.Exp Neurol. 2021 Sep;343:113778. doi: 10.1016/j.expneurol.2021.113778. Epub 2021 Jun 4. Exp Neurol. 2021. PMID: 34090893 Review.
Cited by
-
Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists.ACS Chem Neurosci. 2023 Aug 2;14(15):2727-2742. doi: 10.1021/acschemneuro.3c00267. Epub 2023 Jul 20. ACS Chem Neurosci. 2023. PMID: 37474114 Free PMC article.
-
Novel Psychoactive Phenethylamines: Impact on Genetic Material.Int J Mol Sci. 2020 Dec 17;21(24):9616. doi: 10.3390/ijms21249616. Int J Mol Sci. 2020. PMID: 33348640 Free PMC article.
-
Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression.ACS Pharmacol Transl Sci. 2024 Jan 25;7(2):478-492. doi: 10.1021/acsptsci.3c00297. eCollection 2024 Feb 9. ACS Pharmacol Transl Sci. 2024. PMID: 38357283 Free PMC article.
-
Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited.ACS Pharmacol Transl Sci. 2024 Feb 5;7(3):641-653. doi: 10.1021/acsptsci.3c00192. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481684 Free PMC article.
-
Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists.J Med Chem. 2022 Sep 22;65(18):12031-12043. doi: 10.1021/acs.jmedchem.2c00702. Epub 2022 Sep 13. J Med Chem. 2022. PMID: 36099411 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous